|

Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery

RECRUITINGN/ASponsored by AC Camargo Cancer Center
Actively Recruiting
PhaseN/A
SponsorAC Camargo Cancer Center
Started2025-06-01
Est. completion2027-06-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07268846

Summary

The treatment of colorectal cancer, in the absence of metastases, is primarily based on surgical removal. Colorectal surgery, which involves resecting part of the intestine and restoring intestinal continuity, carries a risk of complications. This study aims to evaluate whether oral supplementation with a postbiotic at a dose of 900 mg for 7 days prior to surgery reduces the rate of postoperative complications.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Individuals diagnosed with malignant neoplasm of the large intestine, specifically adenocarcinoma.
* Patients over 18 years of age, of both sexes.
* Patients who agree to participate in the study and sign the informed consent form.

Exclusion Criteria:

* Emergency or urgent surgeries.
* Cytoreductive surgeries involving intraoperative intraperitoneal chemotherapy.
* Extended surgeries for the treatment of recurrent tumors.

Conditions3

Breast CancerCancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.